These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 11526699)
21. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Aletti GD; Dowdy SC; Gostout BS; Jones MB; Stanhope CR; Wilson TO; Podratz KC; Cliby WA Obstet Gynecol; 2006 Jan; 107(1):77-85. PubMed ID: 16394043 [TBL] [Abstract][Full Text] [Related]
22. Surgical management of mesenteric lymph node metastasis in patients undergoing rectosigmoid colectomy for locally advanced ovarian carcinoma. Salani R; Diaz-Montes T; Giuntoli RL; Bristow RE Ann Surg Oncol; 2007 Dec; 14(12):3552-7. PubMed ID: 17896149 [TBL] [Abstract][Full Text] [Related]
23. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Chi DS; Eisenhauer EL; Zivanovic O; Sonoda Y; Abu-Rustum NR; Levine DA; Guile MW; Bristow RE; Aghajanian C; Barakat RR Gynecol Oncol; 2009 Jul; 114(1):26-31. PubMed ID: 19395008 [TBL] [Abstract][Full Text] [Related]
24. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Poynor EA; Aghajanian C; Jarnagin WR; DeMatteo RP; D'Angelica MI; Barakat RR; Chi DS Gynecol Oncol; 2006 Dec; 103(3):1083-90. PubMed ID: 16890277 [TBL] [Abstract][Full Text] [Related]
28. Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum. Gronlund B; Lundvall L; Christensen IJ; Knudsen JB; Høgdall C Eur J Surg Oncol; 2005 Feb; 31(1):67-73. PubMed ID: 15642428 [TBL] [Abstract][Full Text] [Related]
29. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer. Aletti GD; Dowdy S; Podratz KC; Cliby WA Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488 [TBL] [Abstract][Full Text] [Related]
30. Laparoscopic prophylactic oophorectomy plus N3 lymphadenectomy for advanced rectosigmoid cancer. Liang JT; Lai HS; Wu CT; Huang KC; Lee PH; Shun CT Ann Surg Oncol; 2007 Jul; 14(7):1991-9. PubMed ID: 17447107 [TBL] [Abstract][Full Text] [Related]
31. The surgical management of women with ovarian cancer in the south west of England. Olaitan A; Weeks J; Mocroft A; Smith J; Howe K; Murdoch J Br J Cancer; 2001 Dec; 85(12):1824-30. PubMed ID: 11747321 [TBL] [Abstract][Full Text] [Related]
32. [Peritonectomy in the treatment of ovarian carcinoma at an advanced stage]. Zotti EF; Munegato G; Nicoletto O G Chir; 1993 Feb; 14(2):75-8. PubMed ID: 8489897 [No Abstract] [Full Text] [Related]
33. The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients. Chan JK; Urban R; Hu JM; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Kapp DS Br J Cancer; 2007 Jun; 96(12):1817-22. PubMed ID: 17519907 [TBL] [Abstract][Full Text] [Related]
34. Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer. Salani R; Axtell A; Gerardi M; Holschneider C; Bristow RE Gynecol Oncol; 2008 Feb; 108(2):271-5. PubMed ID: 18164380 [TBL] [Abstract][Full Text] [Related]
35. Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer. Ramirez PT; Slomovitz BM; McQuinn L; Levenback C; Coleman RL Gynecol Oncol; 2006 Dec; 103(3):888-90. PubMed ID: 16806436 [TBL] [Abstract][Full Text] [Related]
36. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S; J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344 [TBL] [Abstract][Full Text] [Related]
37. Factors associated with cytoreducibility among women with ovarian carcinoma. Eltabbakh GH; Mount SL; Beatty B; Simmons-Arnold L; Cooper K; Morgan A Gynecol Oncol; 2004 Nov; 95(2):377-83. PubMed ID: 15491760 [TBL] [Abstract][Full Text] [Related]
38. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Chi DS; Eisenhauer EL; Lang J; Huh J; Haddad L; Abu-Rustum NR; Sonoda Y; Levine DA; Hensley M; Barakat RR Gynecol Oncol; 2006 Nov; 103(2):559-64. PubMed ID: 16714056 [TBL] [Abstract][Full Text] [Related]